SEEPRED: Optimising Screening of Intermediate to High-risk Asymptomatic Sportsmen With Exercise Electrocardiogram

Sponsor
Centre Hospitalier Universitaire de Saint Etienne (Other)
Overall Status
Completed
CT.gov ID
NCT06024863
Collaborator
(none)
1,500
1
96
15.6

Study Details

Study Description

Brief Summary

The importance of exercise electrocardiogram (ECG) is still controversial in the prevention of cardiac events among sportsmen. The aim of this study was to assess the relevance of exercise electrocardiogram (ECG) as a significant prognostic marker for cardiovascular events when any cardiovascular disease (CVD) risk factors are present.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Screening stress test on a bicycle ergometer (usual practise)

Detailed Description

The SEEPRED (Sport, Exercise ECG, prediction) prospective cohort study included leisure time sportsmen over 35 years old who performed exercise electrocardiogram (ECG) screening in the Sports Medicine Unit of the University Hospital of Saint-Etienne from September 2011 to April 2016. Personal, familial history and physical examination were systematically performed before maximal exercise electrocardiogram (ECG). Cardiovascular events and changes in physical activity were searched after exercise electrocardiogram (ECG).

Study Design

Study Type:
Observational
Actual Enrollment :
1500 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Optimising Screening of Intermediate to High-risk Asymptomatic Sportsmen With Exercise Electrocardiogram. The SEEPRED Study.
Actual Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
Jan 1, 2014
Actual Study Completion Date :
Jan 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Sportsmen

Sportsmen (at least 1 hour of physical activity per week) over 35 years of age, referred by their doctor for a screening stress test on a bicycle ergometer in the sports medicine unit from September 2011 to August 2014

Diagnostic Test: Screening stress test on a bicycle ergometer (usual practise)

Outcome Measures

Primary Outcome Measures

  1. Silent Myocardial ischemia (SMI) [Day 1]

    Determine the frequency of exercise-induced silent myocardial ischemia (SMI).

Secondary Outcome Measures

  1. Gender record [Day 1]

    Gender will be recording during medical consultation in order to predict positive exercise ECG

  2. Age record [Day 1]

    Age will be recording during medical consultation in order to predict positive exercise ECG

  3. Physical activity levels record [Day 1]

    Physical activity levels will be recording during medical consultation in order to predict positive exercise ECG

  4. Treatment record [Day 1]

    Treatment will be recording during medical consultation in order to predict positive exercise ECG

  5. Cardiovascular disease (CVD) risk factors record [Day 1]

    Cardiovascular disease (CVD) risk factors will be recording during medical consultation in order to predict positive exercise ECG

  6. Body mass index record [Day 1]

    Body mass index will be recording during medical consultation in order to predict positive exercise ECG

  7. Score>5% record [Day 1]

    SCORE >5% will be recording during medical consultation in order to predict positive exercise ECG

  8. Maximal heart record [Day 1]

    Maximal heart rate will be recording during medical consultation in order to predict positive exercise ECG

  9. Maximal aerobic power record [Day 1]

    Maximal aerobic power will be recording during medical consultation in order to predict positive exercise ECG

  10. Maximal blood lactate level record [Day 1]

    Maximal blood lactate level will be collected in order to predict positive exercise ECG

  11. Suspected SMI [Day 1]

    Exercise ECG screening test

  12. Confirmed SMI [Day 1]

    Exercise ECG screening test

  13. Cardiovascular events [Day 1]

    Exercise ECG screening test

Eligibility Criteria

Criteria

Ages Eligible for Study:
35 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion criteria:
  • Patients referred as asymptomatic by their general practitioner for an exercise electrocardiogram (ECG) screening test carried out as a standard procedure for resuming physical activity

  • Patients referred as a systematic pre-participation screening to be declared an athlete.

Exclusion criteria:
  • Patients with coronary artery disease (CAD) and

  • Patients with uninterpretable ST segment due to bundle branch block

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier de Saint-Etienne Saint-Étienne France 42055

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Saint Etienne

Investigators

  • Principal Investigator: DAVID HUPIN, MD, CHU ST ETIENNE

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Saint Etienne
ClinicalTrials.gov Identifier:
NCT06024863
Other Study ID Numbers:
  • IRBN372016/CHUSTE
First Posted:
Sep 6, 2023
Last Update Posted:
Sep 8, 2023
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Universitaire de Saint Etienne

Study Results

No Results Posted as of Sep 8, 2023